Drug Shortage Report for PMS-EVEROLIMUS

Last updated on 2023-06-09 History
Report ID 166808
Drug Identification Number 02504677
Brand name PMS-EVEROLIMUS
Common or Proper name EVEROLIMUS
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) EVEROLIMUS
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size BLISTER 30
ATC code L01EG
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-15
Estimated end date 2023-06-10
Actual end date 2023-06-06
Shortage status Resolved
Updated date 2023-06-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-08-15 English Compare
v2 2022-08-15 French Compare
v3 2022-08-16 English Compare
v4 2022-09-06 English Compare
v5 2022-09-06 French Compare
v6 2022-10-27 English Compare
v7 2022-10-27 French Compare
v8 2022-10-28 English Compare
v9 2022-10-28 French Compare
v10 2023-02-20 English Compare
v11 2023-02-20 French Compare
v12 2023-05-15 English Compare
v13 2023-05-15 French Compare
v14 2023-06-06 English Compare
v15 2023-06-06 French Compare
v16 2023-06-09 English Compare
v17 2023-06-09 French Compare

Showing 1 to 17 of 17